8 completed, 5 unknown, 4 not yet recruiting, 2 recruiting. 3 Not applicable, 3 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 2, Completed 1 |
| Phase 3 | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 4 | 2 | Completed 2 |
Follow Liver Abscess: new trials by email Literature Review of Liver Abscess trials Research Report on Liver Abscess
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Diloxanide Furoate as Additional Luminal Agent Along With Metronidazole for the Treatment of Amoebic Liver Abscess Diloxanide furoate, Placebo - Liver Abscess, Amoebic Liver Abscess | Phase 3 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 220 | 2026-09-04 | 2026-09-10 |
| Laparoscopic Approach to Pyogenic Liver Abscess Laproscopic - Liver Abscess, Pyogenic | Not applicable | Not yet recruiting | Assiut University | 30 | 2026-01-01 | 2025-12-26 |
| Post-discharge Monitoring Initiative on Outcomes of Post-surgical Patients Early post-surgical discharge with post-surgical home based monitoring, Standard inpatient care until deemed suitable for discharge - Laparoscopy, Discharge Planning | Not applicable | Not yet recruiting | Sengkang General Hospital | 1000 | 2025-06-01 | 2025-05-20 |
| Characteristics and Treatment Outcome of Liver Abscesses: An Observational Study Liver Abscess | Not yet recruiting | Assiut University | 70 | 2025-03-15 | 2025-02-28 | |
| Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess Intravenous beta-lactam antimicrobial for 2 weeks Plus Intravenous Metronidazole (750 mg q 8 hourly) for 2 weeks, Tablet Cefixime (200 mg q 12 hourly) for 2 weeks Plus Tablet Metronidazole (800 mg q 8 hourly) for 2 weeks, Standard medical care - Liver Abscess | Phase 3 | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 220 | 2025-02-25 | 2025-04-13 |
| Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome Autoimmune Hepatitis, Primary Sclerosing Cholangitis | Recruiting | Chungnam National University Hospital | 3000 | 2024-07-08 | 2026-03-20 | |
| Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407) TACE, HCC - Hepatocellular Carcinoma | Unknown | Shengjing Hospital | 400 | 2024-06-30 | 2024-07-03 | |
| A Joint Model Based on Deep Learning to Predict Multidrug-resistant Klebsiella Pneumoniae Liver Abscess Liver Abscess | Unknown | Shengjing Hospital | 550 | 2024-01-01 | 2024-07-17 | |
| An Observational Study of Risk Factors and Long-term Prognosis of Patients With Liver Abscess in the "Real-world" Liver Abscess, Pyogenic, Liver Abscess | Unknown | Nanfang Hospital, Southern Medical University | 160 | 2022-01-01 | 2022-08-08 | |
| Pyogenic Liver Abcess in Guadeloupe Liver Abscess, Pyogenic | Completed | Centre Hospitalier Universitaire de la Guadeloupe | 58 | 2021-03-22 | 2026-05-11 | |
| Risk Factors for Pyogenic Liver Abscess With Carbapenem-resistant Klebsiella Pneumoniae: A Matched Case-control Study drug sensitivity results - Liver Abscess | Completed | Xiangya Hospital of Central South University | 15 | 2020-04-01 | 2022-08-30 | |
| Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess Ciprofloxacin, Cefixime - Liver Abscess | Phase 3 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 140 | 2019-07-01 | 2019-07-22 |
| Risk Factors and Outcomes of Pyogenic Liver Abscess in Adult Liver Recipients: A Match Case Control Study Liver Transplant Abscess | Unknown | Hospital Italiano de Buenos Aires | 126 | 2016-11-22 | 2017-03-03 | |
| Prevalence of Colon Cancer in Pyogenic Liver Abscess Cryptogenic Pyogenic Liver Abscess | Completed | Inje University | 62 | 2014-01-01 | 2016-03-01 | |
| Antibiotics for Klebsiella Liver Abscess Study Ciprofloxacin, Ceftriaxone, Trimethoprim/sulfamethoxazole - Liver Abscess, Pyogenic | Phase 4 | Completed | National University Hospital, Singapore | 152 | 2013-11-05 | 2018-08-27 |
| Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) rk28 ICT, IT LEISH (rK39), Immunochromatographic HAT test - Visceral Leishmaniasis, Human African Trypanosomiasis | Not applicable | Completed | University Hospital, Geneva | 1927 | 2013-01-01 | 2016-10-27 |
| Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions. Gadoxetic Acid Disodium (Eovist, BAY86-4873) - Liver Neoplasms, Adenoma | Completed | Bayer | 52 | 2009-12-01 | 2016-11-28 | |
| Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess Moxifloxacin (Avelox), ceftriaxone - Liver Abscess | Phase 4 | Completed | Kaohsiung Veterans General Hospital. | 24 | 2009-05-01 | 2015-12-02 |
| Prognosis of Failure Treatment of Amebic Liver Abscess Amebic Liver Abscess | Completed | Universidad Autonoma de San Luis Potosà | 40 | 1999-05-01 | 2008-03-24 |
Liver Abscess, Pyogenic (6) · Liver Abscess, Amebic (3) · Carcinoma, Hepatocellular (2) · Abdominal Abscess (1) · Abscess (1) · Adenoma (1) · Brucellosis (1) · Carcinoma (1) · Cholangitis, Sclerosing (1) · Colonic Neoplasms (1) · Gallbladder Diseases (1) · Hepatitis, Autoimmune (1) · Infections (1) · Leishmaniasis, Visceral (1)
Digestive System Diseases (19) · Suppuration (19) · Abdominal Abscess (18) · Abscess (18) · Infections (18) · Liver Diseases (18) · Amebiasis (3) · Digestive System Neoplasms (3) · Liver Diseases, Parasitic (3) · Neoplasms (3) · Neoplasms by Site (3) · Parasitic Diseases (3) · Protozoan Infections (3) · Adenocarcinoma (2)
Ceftriaxone (2) · Ciprofloxacin (2) · Cefixime (1) · Drainage (1) · Ertapenem (1) · Metronidazole (1) · Moxifloxacin (1) · Standard of Care (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · WW Domain-Containing Oxidoreductase (1) · diloxanide furoate (1) · gadolinium ethoxybenzyl DTPA (1) · tyramine-deoxysorbitol (1)
Post Graduate Institute of Medical Education and Research, Chandigarh (3) · Assiut University (2) · Shengjing Hospital (2) · Bayer (1) · Centre Hospitalier Universitaire de la Guadeloupe (1) · Chungnam National University Hospital (1) · Hospital Italiano de Buenos Aires (1) · Inje University (1) · Kaohsiung Veterans General Hospital. (1) · Nanfang Hospital, Southern Medical University (1) · National University Hospital, Singapore (1) · Sengkang General Hospital (1) · Universidad Autonoma de San Luis Potosà (1) · University Hospital, Geneva (1) · Xiangya Hospital of Central South University (1)
China (3) · India (3) · Singapore (2) · South Korea (2) · Taiwan (2) · Argentina (1) · Cambodia (1) · Democratic Republic of the Congo (1) · Guadeloupe (1) · Italy (1) · Japan (1) · Mexico (1) · Nepal (1) · Sudan (1) · United States (1)
Ashraf Mahmoud Othman, doctorate (1) · Deba P Dhibar, MD (1) · Haidi Karam-Allah Ramadan, doctorate (1) · Hyuksoo Eun (1) · Koy Min Chue (1) · Sophia Archuleta, MD (1) · Susan Shin-Jung Lee, M.D., M.Sc (1) · Tae Oh Kim, M.D. (1)
PMID 26092476, PMID 27016900, PMID 27478381, PMID 27812090, PMID 31641767, PMID 33641013, PMID 34593374, PMID 34812790, PMID 35198179, PMID 35491421, PMID 36812167, PMID 37328522, PMID 38769330, PMID 39028346